Multiomic Approaches to Pediatric Inflammatory Bowel Disease

Invention Description
Pediatric Inflammatory Bowel Disease (IBD), encompassing Crohn’s Disease and Ulcerative Colitis, presents significant clinical challenges due to its complex and heterogeneous nature, often leading to lifelong health complications. Current diagnostic and therapeutic strategies are limited by an incomplete understanding of the molecular and microbial mechanisms driving disease onset and progression.
 
Researchers at Arizona State University have developed an integrated multiomic approach combining metagenomics, metatranscriptomics, and metabolomics to comprehensively analyze the gut microbiome and host molecular pathways in pediatric IBD. This advanced methodology enables the identification of novel biomarkers and disease mechanisms that remain undetectable through traditional microbiome composition studies to improve diagnostics and therapies for pediatric IBD.
 
This innovative approach uncovers biomarkers and molecular mechanisms in pediatric Inflammatory Bowel Disease, paving the way for precision diagnostics and targeted therapeutic strategies.
 
Potential Applications
  • Development of diagnostic tools and biomarker panels for pediatric IBD, including Crohn’s Disease and Ulcerative Colitis
  • Personalized medicine strategies targeting pediatric gastrointestinal disorders
  • Pharmaceutical research for novel therapeutic targets in IBD
  • Healthcare services focused on improved disease monitoring and outcome prediction
  • Academic and clinical research expansion in pediatric multiomic biomarker discovery
Benefits and Advantages
  • Integrates multiple omics data for a deeper and more holistic understanding of disease pathology
  • Identifies disease-specific metabolic and molecular signatures beyond microbiome composition
  • Enables detection of potential biomarkers for early diagnosis and personalized treatment
  • Employs advanced sequencing and data analysis methods for high-resolution insights
  • Focuses on under-researched pediatric IBD populations, addressing a critical healthcare gap
For more information about this opportunity, please see
 
For more information about the inventor(s) and their research, please see
Patent Information:
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Multiomic_Approaches_to_Pedi atric_Inflammatory_Bowel_Disease
Keywords:
Bookmark this page
For Information, Contact:
Jovan Heusser
Director of Licensing and Business Development
Skysong Innovations
jovan.heusser@skysonginnovations.com